Drug intelligence / Profile preview

lenzites betulina extract

Development stage
Preclinical
Lead developer
Ramakrishna Mission Vivekananda Centenary College
Modality
Small Molecules
Administration
Oral
01

Overview

Lenzites betulina extract (LBE) is an ethanolic extract derived from the wild mushroom *Lenzites betulina*, a member of the Polyporaceae family. It is currently under preclinical investigation for its anti-cancer properties, particularly against cervical cancer. LBE contains a variety of bioactive compounds, including fatty acids such as 9,12-octadecadienoic acid and sterols like ergosta-5,8,22-trien-3-ol. The extract exerts its anti-tumor effects by inducing apoptosis through the mitochondrial pathway, which involves the generation of reactive oxygen species (ROS), reduction of mitochondrial membrane potential, upregulation of the p53 tumor suppressor gene, and downregulation of anti-apoptotic proteins like Bcl-2. Furthermore, LBE has been shown to arrest the cell cycle at the G2/M checkpoint, induce autophagy, and inhibit metastasis by depolymerizing F-actin filaments and reducing cancer stem cell populations. In vivo studies in mice have demonstrated significant reductions in tumor volume and weight following treatment.

Other names
Lenzites betulina ethanolic extractL. betulina extractethanolic extract of Lenzites betulina
02

Targets

BCL-2 (BCL-2 family)CASP3 (Caspase-3)TP53 (Cellular Tumor Antigen p53 R175H)CASP9 (Caspase-9)Actin filament proteins

Beyond the preview

Go deeper on lenzites betulina extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lenzites betulina extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call